Antioxidant Properties of Synthesized Bicyclic Thiazolopyrimidine Derivatives as Possible Therapeutic Agents
Source abstract
Abstract
Oxidant/antioxidant imbalance in the body has been implicated as one of the pathophysiological mechanisms leading to disease development. Therefore, we searched for a good antioxidant candidate that can be used as a therapeutic agent alone or in combination with other reported drugs. Earlier, we reported the A2A receptor antagonist properties of 7-Imino-3-substituted-2-thioxo-3,7-dihydro-2H-thiazolo[4,5-d]pyrimidin-6-yl)-urea derivatives (compounds 1–12) and the neuroprotective effect of compound 2. Therefore, in the present work, the antioxidant potential of compounds 1–12 was studied. Compounds 1–12 were screened using different (red/ox) tests, such as the Ferric Reducing Antioxidant Power (FRAP) assay, to determine total antioxidant activity, redox status tests (with and without prooxidants) such as Advanced Oxidation Protein Products (AOPP) and Total Oxidative Status (TOS) which measures H2O2 and lipid hydroperoxides, Paraoxonase-1 Enzyme Activity (PON1), Total SH-groups content, and Total Antioxidative Status (TAS) for antioxidant determination. The Prooxidative Score, Antioxidative Score, and Oxy Score were also calculated. From the obtained results, compounds 6 (8720 FRAP value and 39.31 Oxy Score) and 12 (7866 FRAP value and 36.41 Oxy Score) were found to possess significant antioxidant activity with reasonable potential for therapeutic activity.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Synthesis and biological activity · Synthesis and Characterization of Heterocyclic Compounds · Chemical synthesis and pharmacological studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmacy, Faculty of Medical Sciences, University Goce Delčev-Štip, R. Krste Misirkov No. 10-A, POB 201, 2000 Štip, Macedonia
Department for Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Studentski trg 1, 11000 Belgrade, Serbia
Neuropharmaceutical Laboratory Dr. BR Ambedkar Center for Biomedical Research University of Delhi, Delhi 110007, India
Department of Physiology and Pharmacology “Vittorio Erspamer”, Sapienza University of Rome, str. Aldo Moro 5, 00185 Rome, Italy
References (29)
Show source-provided references
1. Role of Reactive Oxygen Species in Cell Signaling Pathways10.1042/bst0290345 ↗
2. Evaluation of total antioxidant status, total oxidant status and oxidative stress index in patients with alopecia areata
3. Oxidative stress and antioxidants in disease and cancer: A review10.7314/APJCP.2014.15.11.4405 ↗
4. Roles of Amyloid β-Peptide-Associated Oxidative Stress and Brain Protein Modifications in the Pathogenesis of Alzheimer’s Disease and Mild Cognitive Impairment10.1016/j.freeradbiomed.2007.05.037 ↗
5. Free radicals, natural antioxidants, and their reaction mechanisms10.1039/C4RA13315C ↗
6. Synthesis of novel triheterocyclicthiazoles as anti-inflammatory and analgesic agents10.1016/j.ejmech.2007.01.023 ↗
7. Synthesis, antioxidant, antitumor activities of some new thiazolopyrimidines, pyrrolothiazolopyrimidines and triazolo-pyrrolothiazolopyrimidines derivatives10.1002/jccs.201190056 ↗
8. Free rsdical scavenging properties of pyrimidine derivatives10.1186/2191-2858-2-34 ↗
9. In vitro antioxidant properties of new thiazole derivatives10.1016/j.jscs.2011.02.007 ↗
10. Synthesis and study of 1,3,5-triazine based thiazole derivatives as antimicrobial agents10.1016/j.jscs.2012.12.004 ↗
11. Liaras, K., Fesatidou, M., and Geronikaki, A. (2018). Thiazoles and thiazolidinones as COX/LOX inhibitors. Molecules, 23.10.3390/molecules23030685 ↗
12. In vitro antioxidant activity of thiazolidinone derivatives of 1,3-thiazole and 1,3,4-thiadiazole10.1016/j.cbi.2018.03.013 ↗
13. Novel thiazole derivatives: A patent review (2008–2012. Part 2)10.1517/13543776.2014.910196 ↗
14. Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent kinase 5/p25 as a potential treatment for Alzheimer’s disease10.1016/j.bmcl.2004.09.006 ↗
15. Slee, D., Lanier, M., Vong, B.G., Chen, Y., Zhang, X., Lin, E., Moorjani, M., and Laria, J.C.C.P. (2008). Substituted pyrimidines as adenosine receptor antagonists. (US2008/0275064), U.S. Patent.
16. Synthesis of novel 7-imino-2-thioxo-3,7-dihydro-2H-thiazolo[4,5-d] pyrimidine derivatives as adenosine A2A receptor antagonists10.1016/j.bmcl.2009.11.133 ↗
17. Luthra, P.M., and Mishra, C.B. (2012). Novel 3-substituted 7-imino-2-thioxo-3,7-dihidro-2H-thiazolo[4,5-dipyrimidin]-6-yl and process for preparation thereof. (US2012/0264937), U.S. Patent.
18. Thiazole: A promising heterocycle for the development of potent CNS active agents10.1016/j.ejmech.2014.12.031 ↗
19. Neuroprotective effect of IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo [4,5-d]pyrimidin-6(7H)-yl)urea) in 6-OHDA induced rodent model of hemiparkinson’s disease10.1016/j.neulet.2018.03.040 ↗
20. Adenosine A2A Receptor Antagonists in Neurodegenerative Diseases: Huge Potential and Huge Challenges10.3389/fpsyt.2018.00068 ↗
21. The ferric-reducing ability of plasma (FRAP) as a measure of “antioxidant power”: The FRAP assay10.1006/abio.1996.0292 ↗
22. Advanced oxidation protein products as a novel marker of oxidative stress in uremia10.1038/ki.1996.186 ↗
23. A new automated colorimetric method for measuring total oxidant status10.1016/j.clinbiochem.2005.08.008 ↗
24. Oxidative stress and paraoxonase 1 status in acute ischemic stroke patients10.1016/j.atherosclerosis.2015.05.016 ↗
25. Determination of paraoxonase (PON1) status requires more than genotyping10.1097/00008571-199912000-00009 ↗
26. Tissue sulfhydril groups10.1016/0003-9861(59)90090-6 ↗
27. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation10.1016/j.clinbiochem.2003.11.015 ↗
28. Identification of non-furan containing A2A antagonists using database mining and molecular similarity approaches10.1016/j.bmcl.2006.08.116 ↗
29. Identification of Novel Adenosine A2A Receptor Antagonists by Virtual Screening10.1021/jm201455y ↗